Sundar Jagannath¹, Joshua Richter, MD¹, Madhav V. Dhodapkar, MD, PhD², James E. Hoffman³, Hans Lee, MD⁴, Attaya Suvannasankha, MD⁵, Mansi R. Shah^6*, Suzanne Lentzsch, MD, PhD⁷, Jeffrey A. Zonder, MD⁸, Rachid Baz, MD⁹, Joseph J. Maly^10*, Swathi Namburi¹¹, Ka Lung Wu, MD, PhD¹², Matthew Pianko¹³, Jing Christine Ye¹³, Rebecca Silbermann¹⁴, Chang-Ki Min^15*, Marie-Christiane Vekemans^16*, Markus Munder^17*, Ja Min Byun^18*, Joaquín Martínez Lopez^19*, Michelle DeVeaux^20*, Dhruti Chokshi^20*, Anita Boyapati^20*, Anasuya Hazra^20*, Karen Rodriguez Lorenc²⁰, Glenn S. Kroog^20*, Yariv Houvras^20* and Naresh Bumma, MD²¹

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Emory University School of Medicine, Atlanta, GA
³University of Miami Health System, Miami, FL
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN
⁶Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁷Division of Hematology & Oncology, Columbia University Medical Center, New York, NY
⁸Karmanos Cancer Institute, Detroit, MI
⁹Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
¹⁰Norton Cancer Institute, Louisville, KY
¹¹Swedish Cancer Institute, Seattle, WA
¹²Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium
¹³Universty of Michigan, Rogel Cancer Center, Ann Arbor, MI
¹⁴Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹⁵Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁶Department of Internal Medicine, Université Catholique de Louvain (UCLouvain), Brussels, Belgium
¹⁷Third Department of Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
¹⁸Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁹Hospital Universitario 12 de octubre, Universidad Complutense, CNIO, Madrid, Spain
²⁰Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²¹The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH

Benjamin A Derman, MD¹, Jennifer H Cooperrider², Jacalyn Rosenblatt, MD³, David Avigan, MD³, Murtuza M. Rampurwala, MD, MPH^4*, Ajay Major, MD, MBA⁵, Theodore Karrison^2*, Ken Jiang^2*, Tadeusz Kubicki^2* and Andrzej J Jakubowiak, MD, PhD⁶

¹Section of Hematology/Oncology, University of Chicago, CHICAGO, IL
²University of Chicago, Chicago, IL
³Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁴University of Wisconsin System, Orland Park, IL
⁵University of Colorado Cancer Center, Aurora, CO
⁶Section of Hematology/Oncology, University of Chicago, Chicago, IL

Gordon Cook, PhD^1,2*, Charlotte Pawlyn, MBBChir, PhD³, Kara-Louise Royle^1*, Ethan R Senior, MMath^1*, Dax Everritt^1*, Jenny Bird^4*, Stella J. Bowcock^5*, Bryony Dawkins^6*, Mark Drayson^7*, Sharon Gillson, BSc^8*, Catherine Olivier^1*, Alan Chant^9*, Matthew W. Jenner^10*, John Robert Jones, MD^11*, Martin F. Kaiser, MD, FRCP, FRCPath¹², Bhuvan Kishore^13*, David Meads, PhD^6*, Neil Rabin^14*, Roger Owen, MD, MRCP, FRCPath^15*, Ruth M de Tute, MSc, PhD, FRCPath^16*, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD^1,17, David Allan Cairns, PhD^18* and Graham Jackson^19*

¹Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
²Leeds Myeloma Research Group and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
³Institute of Cancer Research, Sutton, United Kingdom
⁴Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Cambridge, GBR
⁵Princess Royal University Hospital, King’s College Hospital NHS Foundation Trust,, London, United Kingdom
⁶University of Leeds, Academic Unit of Health Economics, Leeds, United Kingdom
⁷University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
⁸Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, GBR
⁹Patient and Public Contributor, NA, United Kingdom
¹⁰University Hospital Southampton, Southampton, United Kingdom
¹¹East Sussex Healthcare NHS Trust, London, United Kingdom
¹²The Institute of Cancer Research, London, ENG, United Kingdom
¹³Heartofengland NHS FT, Birmingham, GBR
¹⁴Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁵Leeds Teaching Hospitals NHS Trust, Haematological Malignancies Diagnostics Service, Leeds, United Kingdom
¹⁶HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹⁷Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
¹⁸Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, ENG, United Kingdom
¹⁹University of Newcastle, Department of Haematology, Newcastle, United Kingdom

Ehsan Malek, MD¹, Priyanka S. Rana, PhD^2*, Muthulekha Swamydas^2*, Michael Daunov, DO³, Masaru Miyagi^2*, Elena Murphy^2*, James J. Ignatz-Hoover, MD, PhD^4*, Leland Metheny, MD⁵, Seong-Jin Kim^6* and James J. Driscoll II, MD, PhD³

¹Case Western Reserve University, Cleveland, OH
²University Hospitals Cleveland Medical Center, Cleveland
³University Hospitals Cleveland Medical Center, Cleveland, OH
⁴Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
⁵University Hospitals Seidman Cancer Center, Cleveland, OH
⁶Seoul National University, Suwon, KOR

Anupama Kumar, MD¹, Aaron S. Rosenberg, MD², Edward D. Ball, MD³, Sarah M. Larson, MD⁴, Lindsey Sirianni^5*, Carolyn M. Mulroney, MD⁶ and Caitlin L. Costello, MD⁷

¹University of California, San Francisco, San Francisco
²UC Davis Comprehensive Cancer Center, Sacramento, CA
³Division of Bone and Marrow Transplantation, Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁴UCLA Health, UCLA, Los Angeles, CA
⁵Moores Cancer Center, University of California, San Diego, La Jolla
⁶UCSD Moores Cancer Center, La Jolla, CA
⁷University of California, San Diego, La Jolla, CA

Rami Kotb, MD¹, Darrell White, MD², Sita Bhella, MD^3*, Arleigh McCurdy, MD, BSc⁴, Irwindeep Sandhu⁵, Hira Mian, MD⁶, Julie Stakiw, MD, FRCPC⁷, Ibraheem Othman, MD⁸, Jiandong Su, MSc^9*, Aniba Khan, BSc^10*, Engin Gul, BSc, MBA^9* and Donna Reece, MD^9,11

¹Cancer Care Manitoba, Winnipeg, MB, Canada
²Dalhousie University and QEII Health Sciences Centre, Halifax, NS, CAN
³Princess Margaret Cancer Centre, Toronto, Canada
⁴The Ottawa Hospital, Ottawa, ON, Canada
⁵Cross Cancer Institute, Edmonton, AB, Canada
⁶McMaster University, Hamilton, ON, Canada
⁷Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, SK, Canada
⁸Allan Blair Cancer Centre, Regina, SK, CAN
⁹Canadian Myeloma Research Group, Vaughan, ON, Canada
¹⁰Canadian Myeloma Research Group, Vaughan, ON, CAN
¹¹Princess Margaret Cancer Centre, Toronto, ON, Canada

Fredrik Schjesvold, MD, PhD^1,2, Andrew Spencer, MBBS, MD, FRACP, FRCPA^3*, Yael C. Cohen^4,5*, Enrique M Ocio, MD, PhD⁶, Jordi López-Pardo^7*, Anna Maria Cafro, MD^8*, Natalie S. Callander, MD⁹, Jonathan L. Kaufman, MD¹⁰, Meera Mohan, MD¹¹, Martin Wermke, MD^12*, Noriko Doki, MD, PhD¹³, Rebecca Kan^14*, Karolina Kulec^15*, Gina Trabucco^14*, Stan Ye^14*, Romain Sechaud^16*, Cornelia Quadt, MD^16*, Raghav Chawla, MD, PhD¹⁶ and Marc S. Raab^17*

¹Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway, and KG Jebsen Center for B-cell Malignancies, University of Oslo, Oslo, Norway
²KG Jebsen Center for B Cell Malignancies,, University of Oslo, Oslo, Norway
³Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
⁴Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁶Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain
⁷Hospital De La Santa Creu I Sant Pau, Barcelona, Spain
⁸Department of Hematology, GOM Niguarda Hospital, Milan, Milan, ITA
⁹University of Wisconsin Carbone Cancer Center, Madison, WI
¹⁰Winship Cancer Institute, Emory University, Atlanta, GA
¹¹Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
¹²Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
¹³Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
¹⁴Novartis Institutes for Biomedical Research, Cambridge, MA
¹⁵Novartis Ireland Limited, Dublin, Ireland
¹⁶Novartis Institutes for BioMedical Research, Basel, Switzerland
¹⁷Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany

James R Berenson, MD^1,2,3, Andrea Limon^3*, Stephanie Rice^3*, Tahmineh Safaie^3*, Ralph Boccia, MD^4*, Honghao Yang, MD, PhD^5*, Mehdi M. Moezi, MD⁶, Stephen Lim, MD⁷, Gary Schwartz, MD^1*, Shahrooz Eshaghian, MD^8*, Matthew Brobeck^3*, Regina Swift^1*, Benjamin M. Eades^1*, Sean Bujarski^1*, Yohana Sebhat^1*, Rudra Ray^1*, Susanna Kim, PharmD^3* and Robert Allen Vescio, MD⁹

¹Berenson Cancer Center, West Hollywood, CA
²Institute for Myeloma and Bone Cancer Research, West Hollywood, CA
³Oncotherapeutics, West Hollywood, CA
⁴Center for Cancer and Blood Disorders, Bethesda, MD
⁵Global Oncology, Alhambra, CA
⁶Cancer Specialists of North Florida, Fleming Island, FL
⁷Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA
⁸LA Cancer Network, Los Angeles, CA
⁹Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Huixing Zhou^1*, Long Chang^2*, Jing Jia^3*, Jie Ma^4*, Hua Xue^5*, Hao Li^6*, Wenrong Huang⁷, Hebing Zhou^8*, Jingnan Sun^9*, Liping Su^10*, Yanping Ma, PhD^11*, Huang Hongming^12*, Hongmei Jing^13*, Zhenling Li^14*, Guangyu Ma^15*, Guohong Su^16*, Jihao Zhou, MD^17*, Biyun Chen^18*, LI Bao^19*, Zhihua Zhang, MD^20*, Lin Yang^21*, Haiping Yang^22*, Yanhong Zhao^23*, Chunyan Sun^24*, Qingming Wang^25*, Qimuge Saiyin^26*, Da Gao, MD^27*, Xiaoxia Chu, MD^28*, Zhenfang Xi^29*, Weiwei Tian, MD, PhD^30*, Xuliang Shen, MD^31*, Shi Minxia, MD, PhD^32*, Jin Zhang^33*, Yi Chen^34*, Jingbo Xu^35*, Yao Liu, PhD, MD³⁶, Hongling Peng^37*, Weijun Fu^38*, Jun Luo, DO^39*, Zhenyu Li^40*, Hui-Han Wang^41*, Xiaobo Wang^42*, Xiuli Sun^43*, Jinqiao Zhang^44*, Wei WANG, MD, PhD^45*, Yan Yan^46*, Yafei Wang^47*, Xin Du, MD^48*, Yonghuai Feng, PhD^49*, Yi Wang, MD^50*, Ying Sun^51*, Liye Zhong, MD, PhD^52*, Li Gao^53*, Wenming Chen, MD, PhD^54*, Jian Li^55* and Wen Gao, MD, PhD⁵⁶

¹Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
²Department of Hematology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
³Beijing Chao-Yang Hospital, Beijing, China
⁴The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan 450008, PR China, Zhengzhou, China
⁵Affiliated Hospital of Hebei University, Baoding City, Hebei Province, CHN
⁶Qilu Hospital of Shandong University, Jinan, China
⁷The Fifth Medical Center of the General Hospital of the Chinese People's Liberation Army, Beijing, China
⁸Beijing Luhe Hospital, Capital Medical University, Beijing, China
⁹The First Hospital of Jilin University, Changchun, CHN
¹⁰Shanxi Cancer Hospital, Taiyuan, China
¹¹The Second Hospital of Shanxi Medical University, Taiyuan, China
¹²The Affiliated Hospital of Nantong University,, Jiangsu, China
¹³Third Hospital of Peking University, Beijing, CHN
¹⁴China Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing, China, China, China
¹⁵The Forth Hospital of Hebei Medical University, hebei, China
¹⁶Cangzhou Central Hospital, Cangzhou, CHN
¹⁷Department of Hematology, Shenzhen People’s Hospital, Rochester, MN
¹⁸Fujian Provincial Hospital， Fujian Medical University, Fuzhou, China
¹⁹Beijing Jishuitan Hospital, Beijing,, Beijing, CHN
²⁰Affiliated Hospital of Chengde Medical University, Chengde, China
²¹The Second Hospital of Hebe Medical University, Shijiazhuang, Hebei, China, Shijiazhuang, CHN
²²The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
²³Harbin Medical University, Shenyang, CHN
²⁴Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CHN
²⁵the Second Affiliated Hospital of Nanchang University, Nanchang, CHN
²⁶Central Hospital of Ordos, ORDOS, China
²⁷The affiliated hospital of inner mongolia medical univuniversity, Hohhot, China
²⁸The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China
²⁹Department of Hematology, Linfen People's Hospital, Linfen, China
³⁰Shanxi Bethune Hospital, Shanxi, China, Taiyuan, CHN
³¹Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China
³²First Affiliated Hospital of Kunming Medical University, kunming, China
³³Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, hangzhou, China
³⁴The First Affiliated Hospital of Wenzhou Medical University, wenzhou, China
³⁵The Fifth Affiliated Hospital Sun Yat-Sen University,, Zhuhai, CHN
³⁶Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
³⁷Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People's Republic of China, Changsha, China
³⁸Department of Hematology, Myeloma&Lymphoma Center, Shanghai Changzheng Hospital Navy Medical University, Shanghai, China
³⁹The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
⁴⁰The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
⁴¹Shengjing Hospital of China Medical University, Shenyang, CHN
⁴²The Second Hospital of Dalian Medical University, Dalian, China
⁴³The First Affiliated Hospital of Dalian Medical University, Dalian, China
⁴⁴The Third Affiliated Hospital of Hebei University, Shijiazhuang, CHN
⁴⁵The Second Affiliated Hospital of Harbin Medical University, Harbin, CHN
⁴⁶Bayannur Hospital, Inner Mongolia, China
⁴⁷Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁴⁸Division of Hematology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
⁴⁹Department of Hematology, The Affiliated Hospital of Zunyi University, zunyi, China
⁵⁰Shanxi Provincial People‘s Hospital, shanxi, China
⁵¹The Second Affiliated Hospital of Nanchang University, jiangxi, China
⁵²Guangdong Provincial People's Hospital, Guangzhou, CHN
⁵³The Xinqiao Hospital of Third Military Medical University, Chongqing 214426, China., China, China
⁵⁴Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
⁵⁵Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⁵⁶Beijing Chao-Yang Hospital Affiliated to Capital Medical University, Beijing, CHN

Frida Bugge Askeland, MD^1,2*, Anne-Marie Rasmussen, PhD^1,2*, Anna Lysen, PhD^1,2*, Einar Haukås, MD^3*, Anette Løken Eilertsen, MD, PhD^4*, Magnus Moksnes, MD^5*, Galina Tsykunova, MD^6*, Anders Vik, MD, PhD^7,8, Birgitte Dahl Eiken, MD^9*, Vidar Stavseth, MD^10*, Jürgen Rolke, MD^11*, Eivind Ottersen Samstad, MD, PhD^12,13*, Valdas Peceliunas, MD, PhD^14*, Randi Fykse Hallstensen, MD^15*, Ariane Aasbø Hansen^1*, Anita Smith Nilsen^1*, Tobias S. Slørdahl, MD, PhD^16,17* and Fredrik Schjesvold, MD, PhD^1,2

¹Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway
²KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
³Department of Cancer and Blood Diseases, Stavanger University Hospital, Stavanger, Norway
⁴Department of Hematology, Akershus University Hospital, Oslo, Norway
⁵Cancer and Hematology Center, Vestfold Hospital, Tønsberg, Norway
⁶Department of Medicine, Haukeland University Hospital, Bergen, Norway
⁷Department of Hematology, University Hospital of North Norway, Tromso, Norway
⁸Institute of Clinical Medicine, The Artic University of Norway, Tromsø, Norway
⁹Department of Oncology, Hospital Østfold, Kalnes, Fredrikstad, Norway
¹⁰Medical Department, Levanger Hospital, Levanger, Norway
¹¹Department of Hematology, Sørlandet Hospital, Kristiansand, Norway
¹²Department of Medicine, Ålesund Hospital, Ålesund, Norway
¹³Department of Health Sciences in Ålesund, Norwegian University of Science and Technology, Ålesund, Norway
¹⁴Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
¹⁵Department of Hematology, Nordland Hospital, Bodø, Norway
¹⁶Department of Hematology, St. Olavs University Hospital, Trondheim, Norway
¹⁷Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Martha L Louzada, MD, MSc¹, Donna E. Reece, MD², Arleigh McCurdy, MD, BSc³, Rami Kotb, MD⁴, Ibraheem Othman, MD⁵, Hira Mian, MD⁶, Toni Lin, MD, FRCPC^7*, Michael P Chu^8*, Darrell White⁹, Stephen Parkin, MD, BSc^10*, Engin Gul, BSc, MBA^11*, Aniba Khan, BSc^12* and Suzanne Trudel, MD, FRCPC¹³

¹London Health Sciences Centre, London, ON, Canada
²Canadian Myeloma Research Group, Toronto, ON, CAN
³The Ottawa Hospital, Ottawa, ON, Canada
⁴Cancer Care Manitoba, Winnipeg, Canada
⁵Allan Blair Cancer Centre, Regina, SK, CAN
⁶McMaster University, Hamilton, ON, Canada
⁷Western University, London, ON, Canada
⁸Alberta Health Services, Edmonton, AB, Canada
⁹Dalhousie University and QEII Health Sciences Centre, Halifax, NS, CAN
¹⁰Vancouver General Hospital, Vancouver, BC, CAN
¹¹Canadian Myeloma Research Group, Vaughan, ON, Canada
¹²Canadian Myeloma Research Group, Vaughan, ON, CAN
¹³McLaughlin Centre for Molecular Medicine, Toronto, ON, CAN

Sebastian Grosicki, MD, PhD^1*, Torben Plesner, MD^2*, Wojciech Jurczak, MD, PhD³, Jakub Radocha, MD, PhD^4*, Ehsan Malek, MD⁵, Ida Hiemstra, PhD^6*, Lauren K. Brady, PhD⁷, Jenny Chen, MD, PhD^7*, Nian Gong, PhD^7*, Charlotte Hindsberger, MS^8* and Andrew Spencer, MBBS, MD, FRACP, FRCPA^9*

¹Department of Hematology and Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland
²Vejle Hospital, Vejle, Denmark
³Dpt of Clinical Oncology, MSC National Research Institute of Oncology, Kraków, Poland
⁴4th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Králov, Czech Republic
⁵University Hospitals Seidman Cancer Center, Cleveland, OH
⁶Genmab, Utrecht, NLD
⁷Genmab, Plainsboro, NJ
⁸Genmab, Copenhagen, Denmark
⁹Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia

Javier Cepeda-Piorno^1*, Borja Puertas Martínez^2*, Laura Rosiñol, MD, PhD^3,4*, Albert Oriol^5*, Felipe De Arriba, MD, PhD^6*, Luis Palomera, MD, PhD^7*, Miguel Teodoro Hernandez^8*, Jaime Pérez De Oteyza, MD, PhD^9*, Ana Pilar Gonzalez^10*, David Carballo^11*, Veronica Gonzalez-Calle, MD, PhD^12*, Paula Chavez^11*, Vanesa Garcia-Moreira^11*, Enrique M Ocio, MD, PhD¹³, Maria Victoria Mateos, MD, PhD¹⁴ and Esther Gonzalez Garcia, MD^15*

¹Hospital Universitario de Cabueñes, Gijón, AL, ESP
²Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain
³Amyloidosis and Myeloma Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain
⁴Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁵Hematology Department, Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain
⁶Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
⁷Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
⁸Hospital Universitario de Canarias, Universidad de La Laguna, Santa Cruz de Tenerife, Spain
⁹Hematology, Hospital Universitario HM Sanchinarro, Madrid, Spain
¹⁰Hospital Universitario Central de Asturias, Oviedo, Spain
¹¹Hospital Universitario de Cabueñes, Gijón, Spain
¹²University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Salamanca, ESP
¹³Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain
¹⁴University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Salamanca, Spain
¹⁵University Hospital Cabueñes, Gijón, Spain

Jane Miglo, BS^*, Voleak Choeurng, MS^*, Rin Nakamura, MS^* and James Cooper, MD

Genentech, Inc., South San Francisco, CA

Hans Lee, MD¹, June Li^2*, Heather Lin^3*, Astrid D. Murga^1*, Gabriela M Rodriguez^1*, Mostafa E. Mohamed^1*, Jared Henderson^1*, Sarah Rodriguez, PharmD^4*, Melody R. Becnel, MD¹, Donna M. Weber, MD⁵, Swami P. Iyer, MD⁶, Gregory P. Kaufman, MD^1*, Sheeba K. Thomas, MD¹, Elisabet E. Manasanch, MD¹, Krina K. Patel, MD, MSc⁷, Stephen J. Noga, MD, PhD⁴, Michael R. Green, PhD¹, Robert Z. Orlowski, MD, PhD^1,8 and Cara L Haymaker, PhD^2*

¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA
⁵Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX

Cesar Rodriguez, MD^1*, Scott R. Solomon, MD², Barry Paul, MD, MS³, Omar Nadeem, MD⁴, Meenal Patel^5*, Jian Wang^5*, Rongda Xu^5*, Melissa Junttila, PhD^5*, Anneleen Daemen, PhD^6*, Subhash Katewa, PhD^5*, Pratik S Multani, MD, MS^7* and Wilson I. Gonsalves, MD⁸

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
²Northside Hospital Cancer Institute, Atlanta, GA
³Levine Cancer Institute, Charlotte, NC
⁴Dana-Farber, Boston, MA
⁵ORIC Pharmaceuticals, South San Francisco, CA
⁶ORIC Pharmaceuticals, SOUTH SAN FRANCISCO, CA
⁷ORIC Pharmaceuticals, San Diego, CA
⁸Division of Hematology, Mayo Clinic, Rochester, MN

Jeffrey A. Zonder, MD¹, Abdullah Khan², Susanna J. Jacobus, MS^3*, Hani Hassoun, MD⁴, Larry D. Anderson Jr., MD, PhD⁵, Lauren E. Merz, MD, MSc⁶, Rebecca L. Zon, MD^7*, Yvonne Adeduni Efebera, MD, MPH⁸, Tondre Buck, MD^9*, Racquel D. Innis-Shelton, MD^10*, Monique A Hartley-Brown, MD⁶, Sagar Lonial, MD^11*, Erica L. Campagnaro, MD^12*, Peter M. Voorhees, MD¹³, Robert Z. Orlowski, MD, PhD¹⁴, Edward Libby, MD¹⁵, David Duane Hurd, MD^16*, Caitlin L. Costello, MD¹⁷, Noopur S. Raje^18*, Eva Medvedova, MD^19*, Philip L. McCarthy, MD²⁰, Carter P. Milner, MD²¹, Cristina Gasparetto^22*, Mounzer E Agha²³, Krisstina Gowin, DO^24*, Rammurti T. Kamble, MD²⁵, Sundar Jagannath^26*, Nitya Nathwani, MD²⁷, Melissa Alsina, MD^28*, Sergio A. Giralt, MD, FACP⁴, Jacob P. Laubach, MD^6*, Omar Nadeem, MD⁶, Irene M. Ghobrial, MD⁶, Clifton C. Mo, MD⁶, Mehmet K. Samur, PhD^6*, Kenneth C. Anderson, MD²⁹, Nikhil C Munshi, MD^29* and Paul G. Richardson, MD⁶

¹Karmanos Cancer Institute, Detroit, MI
²The Ohio State University Comprehensive Cancer Center, Columbus, OH
³Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Division of Blood and Marrow Transplant/Hematology, OhioHealth, Columbus, OH
⁹Gibbs Cancer Center & Research Institute, Spartanburg, SC
¹⁰Alabama Oncology, University of Alabama at Birmingham, Birmingham, AL
¹¹Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹²Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
¹³Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
¹⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵University of Washington, Division of Medical Oncology and Fred Hutchinson Cancer Center, Seattle, WA
¹⁶Section of Hematology and Oncology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC
¹⁷Moores Cancer Center at University of California San Diego, San Diego, CA
¹⁸Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA
¹⁹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
²⁰Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, NY
²¹Division of Hematology and Oncology, University of Mississippi Medical Center, Jackson, MS
²²Duke Cancer Institute, Durham, NC
²³UPMC Hillman Cancer Center, Pittsburgh, PA
²⁴University of Arizona Cancer Center, UA College of Medicine, Tucson, AZ
²⁵Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX
²⁶Mount Sinai Medical Center, New York, NY
²⁷Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA
²⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²⁹Dana-Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, MA

Chunyan Sun^1*, Baijun Fang, MD^2*, Guangxun Gao^3*, Fuling Zhou, PhD⁴, Aili He^5*, Fei Zhao^1*, Junying Li^1*, Chun Zhang^1*, Li Weiming, MD^1*, Hui Cheng^6*, Huili Cai^7*, Bin Chen^8*, Jingming Guo^7* and Yu Hu, MD^9*

¹Department of Hematology, Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Wuhan, China
²Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³Department of Hematology, Xijing Hospital, Xi’An, China
⁴Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
⁵Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
⁶Department of Hematology, Wuhan No.1 Hospital, Wuhan, China
⁷Department of Hematology, Center People's Hospital of Yichang, Yichang, China
⁸Department of Hematology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China
⁹Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Ajay K. Nooka, MD, MPH¹, Nisha S. Joseph, MD², Vikas A. Gupta, MD, PhD³, Craig C. Hofmeister, MD³, Madhav V. Dhodapkar, MD, PhD³, Bryan J Burton, BSc^4*, Hafsa M Ahmed^4*, Darrian Linton^4*, Annelore Cortoos^5*, Thomas S. Lin, MD, PhD⁶, Richard Labotka⁷, Stephen J. Noga, MD, PhD⁸, Jonathan L. Kaufman, MD¹ and Sagar Lonial, MD^1*

¹Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
²Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Louisville, KY
³Winship Cancer Institute of Emory University, Atlanta
⁴Winship Cancer Institute of Emory University, Atlanta, GA
⁵Janssen Scientific Affairs LLC, Horsham
⁶Johnson & Johnson, Horsham, PA
⁷Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
⁸Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA

Evangelos Terpos, MD, PhD¹, Maria Gavriatopoulou^2*, Ioannis Ntanasis-Stathopoulos, MD, PhD^2*, Panagiotis Malandrakis, MD^2*, Despina Fotiou, MD, PhD^2*, Magdalini Migkou, MD, PhD^2*, Foteini Theodorakakou, MD^2*, Vasiliki Spiliopoulou, MD^2*, Rodanthi Syrigou, MD^2*, Evangelos Eleutherakis-Papaiakovou, MD^2*, Maria Douvali^3*, Giorgos Psarros^4*, Efstathios Kastritis, MD^2* and Meletios A. Dimopoulos, MD, PhD²

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Aktina Center, Ophthalmic Center, Athens, Greece
⁴Health Data Specialists, Dublin, Ireland